Firsekibart for reducing gout attacks over 24 weeks
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial tests a new medicine called Firsekibart for people who have frequent gout attacks. It aims to see if the medicine can reduce the chance of another attack over 24 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old.
- Have gout confirmed by a doctor.
- Have had at least 2 gout attacks in the last year.
- Be in the middle of a gout attack right now.
- Be willing to sign a consent form to join.
- Not have serious heart problems, active infections, or certain lab test issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This trial tests whether a tart cherry effervescent tablet can help lower uric acid levels in people who have high uric acid but have never had a gout attack. High uric acid can lead to gout and other health problems, so finding a safe way to lower it might help prevent these complications.
This study compares taking Firsekibart (a medicine that helps prevent gout attacks) on a fixed schedule versus only when you feel an attack coming on. It is for people who have already been on Firsekibart for 24 weeks without any flares, to see if continuing on a regular schedule is better than taking it "as needed."
This trial tests a new medication called Firsekibart for people with systemic sclerosis (scleroderma). The goal is to see if it helps reduce skin thickening and other symptoms, and it might be an option if standard treatments haven't worked well.
This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.
This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.
Hear when a new Gout Flare trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.